BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Deleted in breast cancer 1 (DBC1; CCAR2); forkhead box P3 (FOXP3)

July 9, 2015 7:00 AM UTC

In vitro and mouse studies suggest inhibiting DBC1 could help treat autoimmune diseases. In vitro studies identified DBC1 as a binding partner of FOXP3, a Treg cell marker. In normal mice, knockout of...